> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # Foundation for Innovative New Diagnostics - URL: https://www.whiteroseintelligence.com/foundation-for-innovative-new-diagnostics/ - Published: 1999-01-02T16:08:00.000Z - Updated: 2025-09-11T21:42:39.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #organization The **Foundation for Innovative New Diagnostics (FIND)** is an international non-governmental organization based in Geneva, Switzerland. ## History On April 24, 2020, FIND co-hosted an event to launch the [Access to COVID-19 Tools Accelerator](https://www.whiteroseintelligence.com/Access-to-COVID-19-Tools-Accelerator) (ACT-Accelerator), an initiative to raise financial support for accelerated research and development, production, and access to COVID-19 tests, therapies, and [vaccines](https://www.whiteroseintelligence.com/COVID-19-vaccine).[\[1\]](#fn1) FIND co-designed the [Global Pandemic Preparedness Summit 2024](https://www.whiteroseintelligence.com/Global-Pandemic-Preparedness-Summit-2024), which took place on July 29-30, 2024, in Rio de Janeiro, Brazil.[\[2\]](#fn2) ## Organization FIND is part of the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) network.[\[3\]](#fn3) ### Personnel | Name | Position | Notes | | ---------------------- | ------------------------------------------------- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | | Ayoade Alakija | Chair[\[4\]](#fn4) | [Access to COVID-19 Tools Accelerator](https://www.whiteroseintelligence.com/Access-to-COVID-19-Tools-Accelerator), African Vaccine Delivery Alliance (AVDA), Government of Nigeria | | Marta Fernández Suárez | Chief Technology Officer[\[5\]](#fn5) | Daktari Diagnostics | | Rick Bright | Board Member[\[6\]](#fn6) | Pandemic Prevention Institute (PPI), [Biomedical Advanced Research and Development Authority](https://www.whiteroseintelligence.com/Biomedical-Advanced-Research-and-Development-Authority) (BARDA), [Administration for Strategic Preparedness and Response](https://www.whiteroseintelligence.com/Administration-for-Strategic-Preparedness-and-Response) (ASPR) | | Emmanuel Agogo | Director, Pandemic Threats Programme[\[7\]](#fn7) | Nigeria Centre for Disease Control and Prevention (NCDC), Resolve to Save Lives | ### Partners FIND is a partner of: - [CommonTrust Network](https://www.whiteroseintelligence.com/CommonTrust-Network)[\[8\]](#fn8) - Fleming Fund[\[9\]](#fn9) - G20 Health & Development Partnership[\[10\]](#fn10) - Global Antibiotic Research & Development Partnership (GARDP)[\[11\]](#fn11) - Global Outbreak Alert and Response Network (GOARN)[\[12\]](#fn12) - H20 Summit[\[13\]](#fn13) - Medicines for Malaria Venture (MMV)[\[14\]](#fn14) - Pandemic Action Network[\[15\]](#fn15) - RBM Partnership to End Malaria[\[16\]](#fn16) ### Funding FIND has received funding from:[\[17\]](#fn17)[\[18\]](#fn18)[\[19\]](#fn19) - [Access to COVID-19 Tools Accelerator](https://www.whiteroseintelligence.com/Access-to-COVID-19-Tools-Accelerator) (ACT-Accelerator)[\[20\]](#fn20) - Anesvad - African Society for Laboratory Medicine (ASLM) - Australian Aid - [BD](https://www.whiteroseintelligence.com/Becton-Dickinson)[\[21\]](#fn21) - [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-Melinda-Gates-Foundation) - BlackRock Foundation[\[22\]](#fn22) - Boston University - [Centers for Disease Control and Prevention](https://www.whiteroseintelligence.com/Centers-for-Disease-Control-and-Prevention) (CDC) - Centre for Cellular and Molecular Biology (CCMB)[\[20:1\]](#fn20) - Centre for Health Research and Innovation[\[20:2\]](#fn20) - Centre for Infectious Disease Research in Zambia (CIDRZ) - Challenge TB[\[21:1\]](#fn21) - Clinton Health Access Initiative (CHAI)[\[20:3\]](#fn20) - [Coalition for Epidemic Preparedness Innovations](https://www.whiteroseintelligence.com/Coalition-for-Epidemic-Preparedness-Innovations) (CEPI) - Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) - CRDF Global - Delhi Network of Positive People (DNP+)[\[21:2\]](#fn21) - Department of Foreign Affairs and Trade - Department of Health and Social Care - Drugs for Neglected Diseases Initiative (DNDi) - ELMA Foundation - END Fund - European and Developing Countries Clinical Trials Partnership (EDCTP) - [European Commission](https://www.whiteroseintelligence.com/European-Commission)[\[23\]](#fn23) - European Union - Federal Ministry for Economic Cooperation and Development - Federal Ministry of Education and Research - Fleming Fund - Fondation Botnar - Foreign, Commonwealth and Development Office (FCDO) - Foundation for Scientific and Technological Development in Health (FIOTEC) - Foundation to Promote Open Society (FPOS) - Fundación Probitas - FutureLearn[\[20:4\]](#fn20) - [Gavi, the Vaccine Alliance](https://www.whiteroseintelligence.com/Gavi-the-Vaccine-Alliance) - [Gilead Sciences](https://www.whiteroseintelligence.com/Gilead-Sciences)[\[20:5\]](#fn20) - Global Affairs Canada - Global Antimicrobial Resistance Innovation Fund (GAMRIF) - Global BioDiagnostics[\[24\]](#fn24) - The Global Fund - Global Health Innovative Technology Fund (GHIT Fund) - Google[\[25\]](#fn25) - Gordon and Betty Moore Foundation - Government of Kuwait - Government of Manipur[\[21:3\]](#fn21) - Government of National Capital Territory of Delhi[\[21:4\]](#fn21) - Government of Portugal - Government of Punjab[\[21:5\]](#fn21) - Horizon 2020 - Indian Council of Medical Research (ICMR)[\[20:6\]](#fn20) - Institute of Liver and Biliary Sciences (ILBS)[\[21:6\]](#fn21) - Intellectual Ventures[\[24:1\]](#fn24) - International Committee of the Red Cross (ICRC) - International Tuberculosis Research Center (ITRC)[\[21:7\]](#fn21) - International Union Against Tuberculosis and Lung Disease[\[26\]](#fn26) - Irish Aid[\[25:1\]](#fn25) - [Janssen](https://www.whiteroseintelligence.com/Janssen)[\[20:7\]](#fn20) - Jhpiego - John Snow, Inc. (JSI)[\[26:1\]](#fn26) - JSI Research & Training Institute - KfW - KHPT[\[20:8\]](#fn20) - King George's Medical University (KGMU)[\[20:9\]](#fn20) - Kingdom of Saudi Arabia Ministry of Health - KNCV Tuberculosis Foundation - Leona M. and Harry B. Helmsley Charitable Trust - London School of Hygiene and Tropical Medicine[\[20:10\]](#fn20) - Medicor Foundation - Ministry of Foreign Affairs of the Netherlands - Mongolia Ministry of Health - Municipal Corporation of Greater Mumbai[\[20:11\]](#fn20) - MYRADA[\[20:12\]](#fn20) - National Institute of Immunology (NII)[\[20:13\]](#fn20) - [National Institutes of Health](https://www.whiteroseintelligence.com/National-Institutes-of-Health) (NIH) - National Tuberculosis Elimination Programme (NTEP)[\[27\]](#fn27) - Norwegian Agency for Development Cooperation (Norad) - Optum - PanIIT Alumni Foundation[\[20:14\]](#fn20) - Patrick J. McGovern Foundation - Paul G. Allen Family Foundation - PepsiCo - Permanent Mission of the State of Kuwait to the United Nations - Program for Appropriate Technology in Health (PATH)[\[21:8\]](#fn21) - Republic and State of Geneva - Research Investment for Global Health Technology Foundation (RIGHT Foundation) - Resolve to Save Lives - Rockefeller Foundation - Save the Children International[\[28\]](#fn28) - South African Medical Research Council (SAMRC) - State Secretariat for Education, Research and Innovation (SERI) - Stop TB Partnership - Swiss Agency for Development and Cooperation (SDC) - Swiss Tropical and Public Health Institute (Swiss TPH)[\[22:1\]](#fn22) - Tata Institute of Fundamental Research (TIFR)[\[20:15\]](#fn20) - TB Alert India[\[20:16\]](#fn20) - TB REACH - Tetra Pak - Top Institute Pharma[\[29\]](#fn29) - Trafigura Foundation - UBS Optimus Foundation - UKaid - Unitaid - United Nations Office for Project Services (UNOPS) - United States Agency for International Development (USAID) - University of New South Wales (UNSW) - Wellcome Trust - [World Bank](https://www.whiteroseintelligence.com/World-Bank) - [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) (WHO) - World Health Partners (WHP)[\[20:17\]](#fn20) - YR Gaitonde Centre for AIDS Research and Education (YRGCARE)[\[21:9\]](#fn21) ## Activities FIND has provided funding to: - [Access to COVID-19 Tools Accelerator](https://www.whiteroseintelligence.com/Access-to-COVID-19-Tools-Accelerator) (ACT-Accelerator)[\[30\]](#fn30) - [CDC Foundation](https://www.whiteroseintelligence.com/CDC-Foundation)[\[31\]](#fn31) - [Infectious Diseases Institute](https://www.whiteroseintelligence.com/Infectious-Diseases-Institute) (IDI)[\[32\]](#fn32) - [World Health Organization](https://www.whiteroseintelligence.com/World-Health-Organization) (WHO)[\[33\]](#fn33) ## External links - [Campfire Wiki](https://www.campfire.wiki/doku.php?id=foundation%5Ffor%5Finnovative%5Fnew%5Fdiagnostics) - [Website](https://www.finddx.org/) - [Wikipedia](https://en.wikipedia.org/wiki/FIND,%5Fthe%5Fglobal%5Falliance%5Ffor%5Fdiagnostics) --- 1. *What is the ACT-Accelerator.* World Health Organization. Retrieved February 12, 2023, from [↩︎](#fnref1) 2. *Global Pandemic Preparedness Summit.* Coalition for Epidemic Preparedness Innovations. Retrieved August 10, 2024, from [↩︎](#fnref2) 3. *Global Accelerator Network.* CARB-X. Retrieved June 6, 2022, from [↩︎](#fnref3) 4. *Ayoade (Yodi) Alakija, Chair.* Foundation for Innovative New Diagnostics. Retrieved September 4, 2025, from [↩︎](#fnref4) 5. *Marta Fernández Suárez.* Foundation for Innovative New Diagnostics. Retrieved February 23, 2024, from [↩︎](#fnref5) 6. *Rick Bright.* Foundation for Innovative New Diagnostics. Retrieved September 4, 2025, from [↩︎](#fnref6) 7. *Emmanuel Agogo.* Foundation for Innovative New Diagnostics. Retrieved September 11, 2025, from [↩︎](#fnref7) 8. *Home*. CommonTrust Network. Retrieved April 14, 2021, from [↩︎](#fnref8) 9. *Partners.* Fleming Fund. Retrieved June 6, 2022, from [↩︎](#fnref9) 10. *Partners*. G20 Health & Development Partnership. Retrieved December 7, 2022, from [↩︎](#fnref10) 11. Balasegaram, M., & Laxminarayan, R. (2022, October 14). *GARDP Interactive Activity Report 2021*. GARDP. [↩︎](#fnref11) 12. *About Us.* GOARN. Retrieved March 14, 2023, from [↩︎](#fnref12) 13. *Partners*. G20 Health & Development Partnership. Retrieved December 7, 2022, from [↩︎](#fnref13) 14. *Other product development partnerships (PDPs)*. Medicines for Malaria Venture. Retrieved July 17, 2022, from [↩︎](#fnref14) 15. *Our Network*. Pandemic Action Network. Retrieved July 23, 2022, from [↩︎](#fnref15) 16. *Partners*. RBM Partnership to End Malaria. Retrieved September 21, 2022, from [↩︎](#fnref16) 17. *Partners & Donors*. Foundation for Innovative New Diagnostics. Retrieved May 23, 2021, from [↩︎](#fnref17) 18. Alakija, A. (2025, January 21). *Activity Report 2023* (p. 25). Foundation for Innovative New Diagnostics. [↩︎](#fnref18) 19. Kessel, M., & Rodriguez, B. (2022, December 8). *2015-2020 Impact Report* (p. 23). Foundation for Innovative New Diagnostics. [↩︎](#fnref19) 20. *Activity Report India 2020* (p. 19). (2022, December 8). Foundation for Innovative New Diagnostics. [↩︎](#fnref20) [↩︎](#fnref20:1) [↩︎](#fnref20:2) [↩︎](#fnref20:3) [↩︎](#fnref20:4) [↩︎](#fnref20:5) [↩︎](#fnref20:6) [↩︎](#fnref20:7) [↩︎](#fnref20:8) [↩︎](#fnref20:9) [↩︎](#fnref20:10) [↩︎](#fnref20:11) [↩︎](#fnref20:12) [↩︎](#fnref20:13) [↩︎](#fnref20:14) [↩︎](#fnref20:15) [↩︎](#fnref20:16) [↩︎](#fnref20:17) 21. Sarin, S. (2022, December 8). *2019 Activity Report* (p. 25). Foundation for Innovative New Diagnostics. [↩︎](#fnref21) [↩︎](#fnref21:1) [↩︎](#fnref21:2) [↩︎](#fnref21:3) [↩︎](#fnref21:4) [↩︎](#fnref21:5) [↩︎](#fnref21:6) [↩︎](#fnref21:7) [↩︎](#fnref21:8) [↩︎](#fnref21:9) 22. Kessel, M., & Rodriguez, B. (2024, January 10). *Activity Report 2022* (p. 24). Foundation for Innovative New Diagnostics. [↩︎](#fnref22) [↩︎](#fnref22:1) 23. Kessel, M., & Boehme, C. (2022, December 8). *Annual Report 2019* (p. 24). Foundation for Innovative New Diagnostics. [↩︎](#fnref23) 24. Boehme, C., & Kessel, M. (2014, April 2). *Annual Report 2013* (p. 50). Foundation for Innovative New Diagnostics. [↩︎](#fnref24) [↩︎](#fnref24:1) 25. *Annual Report 2008* (p. 34). (2009, August 10). Foundation for Innovative New Diagnostics. [↩︎](#fnref25) [↩︎](#fnref25:1) 26. Kessel, M., & Boehme, C. (2022a, December 8). *Annual Report 2016* (p. 37). Foundation for Innovative New Diagnostics. [↩︎](#fnref26) [↩︎](#fnref26:1) 27. *FIND Annual report 2021.* Canva; Foundation for Innovative New Diagnostics. Retrieved September 11, 2025, from [↩︎](#fnref27) 28. Boehme, C., & Kessel, M. (2022, December 8). *Annual Report 2017* (p. 25). Foundation for Innovative New Diagnostics. [↩︎](#fnref28) 29. Boehme, C., & Kessel, M. (2015, April 14). *Annual Report 2014* (p. 14). Foundation for Innovative New Diagnostics. [↩︎](#fnref29) 30. *Access to COVID-19 tools funding commitment tracker.* (2022, April 1). World Health Organization. [↩︎](#fnref30) 31. *Corporations, Foundations & Organizations - FY2019.* CDC Foundation. Retrieved July 31, 2022, from [↩︎](#fnref31) 32. *Annual Report July 2013 - June 2014* (p. 37). Infectious Diseases Institute. Retrieved July 6, 2017, from [↩︎](#fnref32) 33. *Voluntary contributions by fund and by contributor, 2021* (p. 7). (2022). World Health Organization. [↩︎](#fnref33)